TRIM26 and hepatocellular carcinoma: In comparison to the immortalized normal liver cell line L02, the expression of TRIM26 was reduced in hepatocellular carcinoma samples and several cell lines, such as HepG2, which enhanced hepatocellular carcinoma cell proliferation and clone formation, promoted hepatocellular carcinoma cell proliferation and invasion, as well as affected metabolic reprogramming of tumor cells [67].